Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145054 | SCV000192094 | benign | not specified | 2014-02-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081429 | SCV000291348 | likely benign | Developmental and epileptic encephalopathy, 1; Intellectual disability, X-linked, with or without seizures, arx-related | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000152797 | SCV000564595 | likely benign | not provided | 2023-02-06 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ambry Genetics | RCV000624905 | SCV000741999 | benign | Inborn genetic diseases | 2023-08-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000990556 | SCV001141567 | benign | Developmental and epileptic encephalopathy, 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000152797 | SCV002546154 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ARX: BP3 |
Prevention |
RCV003422032 | SCV004118434 | uncertain significance | ARX-related disorder | 2023-10-12 | criteria provided, single submitter | clinical testing | The ARX c.333_335dupGGC variant is predicted to result in an in-frame duplication (p.Ala115dup). This variant was reported as a maternally-inherited variant in two unrelated male individuals with intellectual disability/developmental delay (reported as c.333_334ins(GCG) in patients #39589 and #41263, Gronskov et al. 2004. PubMed ID: 15199382). However, this variant was not found in a similarly affected family member of the patient #39589 but was identified in an unaffected male control in the same study, suggested by the author that this variant is a rare polymorphism. This variant is reported in 0.078% of alleles in individuals of African descent in gnomAD and has been documented in a hemizygous individual (http://gnomad.broadinstitute.org/variant/X-25031776-T-TGCC). In ClinVar, this variant has conflicting interpretations ranging from benign to uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/157755/). This variant falls within a low complexity region, therefore the allele frequency data should be interpreted with caution. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Eurofins Ntd Llc |
RCV000152797 | SCV000202187 | uncertain significance | not provided | 2014-03-18 | no assertion criteria provided | clinical testing |